Publications by authors named "R Nisini"

The immunization of mice with the sterile culture medium supernatants of (Mtb) H37Rv permitted the production of several monoclonal antibodies (mAbs) specific for secreted and/or released antigens. Two mAbs bound and immunoprecipitated an 80-kDa protein that was identified by mass spectrometry as Rv1133c, the methionine synthase MetE. The protein MetE is ubiquitous among prokaryota and shows a significant sequence homology in many bacteria.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers assessed whether protective antibodies against the vaccinia virus (VV) persist for over 45 years post-vaccination and if they can neutralize the Mpox virus (MPXV).
  • They collected blood samples from smallpox-vaccinated individuals, unvaccinated donors, and those recovering from MPXV infection to conduct various tests, including ELISA, Western blot, and neutralization assays.
  • Findings revealed that vaccinated and convalescent individuals had strong antibody responses that could neutralize MPXV, indicating that the smallpox vaccine creates lasting immunity and that VV antibodies can effectively respond to MPXV.
View Article and Find Full Text PDF

We investigated SARS-CoV-2 variants circulating, from November 2020 to March 2022, among military and civilian personnel at an Air Force airport in Italy in order to classify viral isolates in a potential hotspot for virus spread. Positive samples were subjected to Next-Generation Sequencing (NGS) of the whole viral genome and Sanger sequencing of the spike coding region. Phylogenetic analysis classified viral isolates and traced their evolutionary relationships.

View Article and Find Full Text PDF

In 1918 many countries, but not Spain, were fighting World War I. Spanish press could report about the diffusion and severity of a new infection without censorship for the first-time, so that this pandemic is commonly defined as "Spanish flu", even though Spain was not its place of origin. "Spanish flu" was one of the deadliest pandemics in history and has been frequently compared with the coronavirus disease (COVID)-19 pandemic.

View Article and Find Full Text PDF

Several COVID-19 vaccine strategies utilizing new formulations for the induction of neutralizing antibodies (nAbs) and T cell immunity are still under evaluation in preclinical and clinical studies. Here we used Simian Immunodeficiency Virus (SIV)-based integrase defective lentiviral vector (IDLV) delivering different conformations of membrane-tethered Spike protein in the mouse immunogenicity model, with the aim of inducing persistent nAbs against multiple SARS-CoV-2 variants of concern (VoC). Spike modifications included prefusion-stabilizing double proline (2P) substitutions, mutations at the furin cleavage site (FCS), D614G mutation and truncation of the cytoplasmic tail (delta21) of ancestral and Beta (B.

View Article and Find Full Text PDF